Preferred Label : teduglutide;
MeSH note : glucagon-like peptide 2 (GLP-2) analog; protects small intestinal stem cells from
radiation damage;
MeSH synonym : Gly(2)-GLP-2; (Gly2)GLP-2;
Is substance : O;
UNII : 7M19191IKG;
Origin ID : C494910;
UMLS CUI : C1530889;
ATC code(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
Exact mapping(s) to DCI
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3518114/fr/revestive-teduglutide-syndrome-du-grele-court-chez-l-adulte
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
teduglutide
gastrointestinal agents
evaluation of the transparency committee
adult
teduglutide
short bowel syndrome
---
https://www.has-sante.fr/portail/jcms/c_2752866/fr/revestive-teduglutide-analogue-de-synthese-du-glp-2
https://www.has-sante.fr/portail/jcms/c_2752866/fr/revestive
2017
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
teduglutide
teduglutide
short bowel syndrome
treatment outcome
parenteral nutrition
insurance, health, reimbursement
orphan drug production
injections, subcutaneous
continuity of patient care
Small Intestine Resection
risk management
drug monitoring
intestine, small
child
adolescent
teduglutide
glucagon-like peptide 2
peptides
peptides
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00267
2015
false
false
false
false
Canada
French
drug information
Product containing teduglutide in parenteral dose form (medicinal product form)
teduglutide
teduglutide
peptides
---
http://www.has-sante.fr/portail/jcms/c_2007289/fr/revestive-teduglutide-analogue-de-synthese-du-glp-2
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
teduglutide
teduglutide
short bowel syndrome
treatment outcome
adult
parenteral nutrition
insurance, health, reimbursement
orphan drug production
injections, subcutaneous
continuity of patient care
Small Intestine Resection
adaptation, physiological
risk management
drug monitoring
intestine, small
teduglutide
glucagon-like peptide 2
peptides
peptides
---
http://www.has-sante.fr/portail/jcms/c_2582560/fr/revestive
http://www.has-sante.fr/portail/jcms/c_2007289/fr/revestive
2015
false
false
false
France
French
evaluation of the transparency committee
teduglutide
teduglutide
short bowel syndrome
treatment outcome
adult
parenteral nutrition
insurance, health, reimbursement
orphan drug production
injections, subcutaneous
continuity of patient care
Small Intestine Resection
adaptation, physiological
risk management
drug monitoring
intestine, small
teduglutide
glucagon-like peptide 2
peptides
peptides
---
https://www.ema.europa.eu/medicines/human/EPAR/Revestive
2012
false
United Kingdom
French
English
teduglutide
adult
aged
breast feeding
dna, recombinant
drug evaluation, preclinical
injections, subcutaneous
orphan drug production
peptides
peptides
pregnancy
short bowel syndrome
treatment outcome
drug approval
clinical trials, phase iii as topic
glucagon-like peptide 2
teduglutide
teduglutide
drug evaluation
syndication feed
summary of product characteristics
package leaflet
---